Ligand validation:4CWY

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 4CWY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CWY_HEM_B_500	98%	4%	0.061	0.986	2.34	3.14	15	22	4	0	100%	1
4CWY_HEM_A_500	98%	4%	0.063	0.985	2.34	3.3	17	23	2	0	100%	1
5ADL_HEM_B_500	100%	12%	0.045	0.989	2	2.04	8	9	0	0	100%	1
4D3A_HEM_A_500	100%	19%	0.047	0.989	1.9	1.58	5	6	2	0	100%	1
4D39_HEM_B_500	99%	15%	0.049	0.989	1.84	1.94	4	11	1	0	100%	1
4D35_HEM_A_500	99%	14%	0.049	0.987	1.29	2.53	2	20	3	0	100%	1
4UPT_HEM_B_500	99%	21%	0.05	0.987	1.31	1.99	4	11	0	0	100%	1
1FHF_HEM_A_350	100%	17%	0.021	0.997	1.8	1.82	12	3	4	0	100%	1
1HBH_HEM_B_148	100%	19%	0.016	0.998	1.59	1.89	8	11	2	0	100%	1
2D2C_HEM_A_301	100%	9%	0.024	0.999	2.2	2.28	9	12	4	0	100%	1
3EJD_HEM_B_405	100%	17%	0.018	0.998	1.9	1.69	6	8	2	0	100%	1
3EJE_HEM_B_405	100%	18%	0.022	0.997	1.91	1.6	8	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.